DGX•benzinga•
Quest Diagnostics Reaffirmed 2025 Guidance For Revenue Of $10.70B-$10.85B (Vs. Cons. Of $10.769B), Adjusted EPS Of $9.55-$9.80 (Vs. Cons. Of $9.71)
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 19, 2025 by benzinga